Now showing items 1-3 of 3

    • O'Ryan Gallardo, Miguel; Lucero, Yalda; Linhares, Alexandre C. (2011)
      Rotarix® was first licensed in 2004 and rapidly introduced into private and public markets worldwide. In a previous 2009 article, we reviewed the impact of rotavirus-associated disease, the rationale for different vaccines, ...
    • Ramani, Sasirekha; Mamani Manzano, Nora Herminia; Villena Martínez, Rodolfo Javier; Bandyopadhyay, Ananda S.; Gast, Chris; Sato, Alicia; Laucirica, Daniel; Clemens, Ralf; Estes, Mary K.; O'Ryan Gallardo, Miguel (2016)
      Background: Vaccine schedules including bivalent oral and inactivated poliovirus vaccines will replace trivalent oral poliovirus vaccines in 2016. Methods: We evaluated rotavirus immunoglobulin A seroresponses when the ...
    • Prados Rosales, Rafael; Carreño Márquez, Leandro Javier; Weinrick, Brian; Batista González, Ana; Glatman Freedman, Aarona; Jiayong, Xu; Chan, John; William R., Jacobs Jr.; Porcelli, Steven A.; Casadevall, Arturo (2016)
      Background. Bacillus Calmette-Guerin (BCG) vaccine is widely used for the prevention of tuberculosis, despite limited efficacy. Most immunological studies of BCG or Mycobacterium tuberculosis strains grow bacteria in the ...